|Systematic (IUPAC) name|
|Molecular mass||393,53 g/mol|
ADAMANTYL-THPINACA is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It was first discovered in Slovenia as part of a seizure of 746 grams of white powder and 2 kilograms of brown/green plant material in October 2014.
ADAMANTYL-THPINACA is banned in Sweden.
- "Muuntohuumeiden esiintyvyys 2015" (PDF). Finnish Medicines Agency. 7 May 2015. Retrieved 24 July 2015.
- "Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara". Folkhälsomyndigheten. Retrieved 24 July 2015.